• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem High impedance (1291)
Patient Problems Pulmonary Embolism (1498); Stroke/CVA (1770); Intracranial Hemorrhage (1891)
Event Date 01/11/2023
Event Type  Death  
Event Description
It was reported that the patient underwent a revision procedure to replace the deep brain stimulation (dbs) lead due to low impedances and a short between contact one and seven.It was noted that the lead prevented the patient from getting magnetic resonance imaging (mri).The physician decided to replace the lead instead of implanting a second lead on the other side.The procedure went as expected and the patient was awake for the procedure.Following the procedure, the patient had a post-operative computerized tomography (ct) scan and a brain bleed was discovered.The patient remained in the hospital following the procedure.After a couple days, the patient seemed to be doing better.However, the patient developed other complications and passed away early morning.The explanted lead is expected to be returned for device analysis.
 
Event Description
It was reported that the patient underwent a revision procedure to replace the deep brain stimulation (dbs) lead due to low impedances and a short between contact one and seven.It was noted that the lead prevented the patient from getting magnetic resonance imaging (mri).The physician decided to replace the lead instead of implanting a second lead on the other side.The procedure went as expected and the patient was awake for the procedure.Following the procedure, the patient had a post-operative computerized tomography (ct) scan and a brain bleed was discovered.The patient remained in the hospital following the procedure.After a couple days, the patient seemed to be doing better.However, the patient developed other complications and passed away early morning.The explanted lead is expected to be returned for device analysis.Additional information was received that the lead revision caused bleeding in the brain and a stroke.Following the procedure, the patient had a pulmonary embolism, which led to the patients death.
 
Manufacturer Narrative
Additional suspect medical device component involved in the event: product family: dbs-linear leads.Upn: m365db2202450.Model: db-2202-45.Serial: (b)(6).Batch: 7099225.The returned lead db-2202-45 serial number (b)(6) was analyzed and the reported observations could not be confirmed with testing of the product return.However, visual inspection revealed that the lead was cleanly cut into two pieces approximately 20.5 cm from the distal end of the lead.The clean-cut damage is a result of a typical explant procedure.No other anomalies were identified on the returned portion of the lead.A labeling review was performed on the returned lead db-2202-45 serial number (b)(6) and it did not reveal any anomalies.The instructions for use (ifu) states that injury to areas next to the implant, such as blood vessels, nerves, the chest wall, and the brain, death, and failure or malfunction of any part of the device, including but not limited to: battery leakage, battery failure, lead or extension breakage, hardware malfunctions, loose connections, electrical shorts or open circuits, and lead insulation breaches, whether or not these problems require device removal and/or replacement are known risks with the use of deep brain stimulation.Laboratory analysis of the returned device did not reveal any anomalies on the returned portion of the lead aside from the clean-cut.Technicians confirmed through technical analysis that the clean cut damage was a result of a typical procedure and it is not considered the reason for the reported event.The electrical test could not be performed due to the cut lead body.Additionally, a labeling review was conducted and this review determined that the reported hemorrhage and death are known risks with the use of deep brain stimulation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key16279494
MDR Text Key308576483
Report Number3006630150-2023-00340
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date10/15/2022
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7077422
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/11/2023
Initial Date FDA Received02/01/2023
Supplement Dates Manufacturer Received02/06/2023
Supplement Dates FDA Received02/16/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age66 YR
Patient SexMale
-
-